Harvard University, Cambridge, Massachusetts, USA.
Health Aff (Millwood). 2011 Dec;30(12):2243-51. doi: 10.1377/hlthaff.2010.0255.
The Affordable Care Act of 2010 created the Patient-Centered Outcomes Research Institute to promote and fund comparative effectiveness research and to ensure that the product of this research improves real-world health care decisions. Notwithstanding limitations imposed by Congress on the institute's ability to influence federal payers' coverage and payment policies, the organization now has considerable potential to help standardize and coordinate comparative effectiveness research in the United States. Still, many questions remain about how this important new entity will function--and a central challenge will be to produce comparative effectiveness assessments that can be readily disseminated to, and used by, a wide range of health care stakeholders, especially providers and patients. I recommend that the institute adopt a comparative effectiveness assessment format that compares interventions on the basis of their clinical risks and benefits, economic considerations, and the insights they might offer into medical care. I also offer an example of how this proposed assessment and rating approach might work in the presentation of findings that weigh cardiac bypass versus angioplasty as alternatives for the treatment of coronary disease in which multiple coronary arteries require intervention.
2010 年的平价医疗法案创建了以患者为中心的医疗成果研究所,以促进和资助比较有效性研究,并确保这项研究的成果改善现实世界中的医疗决策。尽管国会对该研究所影响联邦支付者的覆盖范围和支付政策的能力施加了限制,但该组织现在有相当大的潜力来帮助规范和协调美国的比较有效性研究。尽管如此,关于这个重要的新实体将如何运作,仍然存在许多问题,而一个核心挑战将是制定比较有效性评估,以便能够广泛传播给,并且由,广泛的医疗保健利益相关者,特别是提供者和患者。我建议该研究所采用一种比较有效性评估格式,根据干预措施的临床风险和收益、经济考虑因素,以及它们可能提供的医疗保健见解,对干预措施进行比较。我还提供了一个例子,说明如何在提出评估结果时采用这种建议的评估和评级方法,以权衡心脏旁路手术与血管成形术作为治疗需要介入的多条冠状动脉的冠心病的替代方法。